Cargando…

Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic resulted in more than five hundred million infected cases worldwide. The current study aimed to screen the correlation of different laboratory findings with disease severity and clinical outcomes of coronavirus disease (COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Fathalla, Lamiaa A, Kamal, Lamyaa M, Salaheldin, Omina, Khalil, Mahmoud A, Kamel, Mahmoud M, Fahim, Hagar H, Abdel-Moneim, Youssef AS, Abdulhakim, Jawaher A, Abdel-Moneim, Ahmed S, El-Meligui, Yomna M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150244/
https://www.ncbi.nlm.nih.gov/pubmed/35622504
http://dx.doi.org/10.1177/03946320221096207
_version_ 1784717376494764032
author Fathalla, Lamiaa A
Kamal, Lamyaa M
Salaheldin, Omina
Khalil, Mahmoud A
Kamel, Mahmoud M
Fahim, Hagar H
Abdel-Moneim, Youssef AS
Abdulhakim, Jawaher A
Abdel-Moneim, Ahmed S
El-Meligui, Yomna M
author_facet Fathalla, Lamiaa A
Kamal, Lamyaa M
Salaheldin, Omina
Khalil, Mahmoud A
Kamel, Mahmoud M
Fahim, Hagar H
Abdel-Moneim, Youssef AS
Abdulhakim, Jawaher A
Abdel-Moneim, Ahmed S
El-Meligui, Yomna M
author_sort Fathalla, Lamiaa A
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic resulted in more than five hundred million infected cases worldwide. The current study aimed to screen the correlation of different laboratory findings with disease severity and clinical outcomes of coronavirus disease (COVID-19) among Egyptian patients to obtain prognostic indicators of disease severity and outcome. A total of 112 laboratory-confirmed COVID-19 patients were examined. According to the severity of the disease, these patients were divided into three main groups: mild, moderate and severe cases. In addition, clinical characteristics and laboratory findings, including Hb, platelet count, white blood cell count, lymphocyte percentage, neutrophil percentage, neutrophil lymphocyte ratio (NLR), D-dimer, highly sensitive C-reactive protein (HS-CRP), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and creatinine, were measured. The presence of hypertension and/or diabetes was found to be a significant risk factor for disease severity and poor outcome. Increased respiratory rate, levels of SpO(2), HS-CRP, D-dimer, NLR, ALT, LDH, lymphopenia and neutrophilia, as well as changes in chest computed tomography (CT), were associated with increased disease severity and fatal consequences. Highly sensitive C-reactive protein, D-dimer, NLR and LDH constituted excellent predictors for both disease severity and death. Laboratory biomarkers, such as HS-CRP, D-dimer, NLR and LDH, are excellent predictors for both disease severity and death. They can predict mortality in patients at the time of admission secondary to SARS-CoV-2 infection and can help physicians identify high-risk patients before clinical deterioration.
format Online
Article
Text
id pubmed-9150244
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-91502442022-05-31 Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients Fathalla, Lamiaa A Kamal, Lamyaa M Salaheldin, Omina Khalil, Mahmoud A Kamel, Mahmoud M Fahim, Hagar H Abdel-Moneim, Youssef AS Abdulhakim, Jawaher A Abdel-Moneim, Ahmed S El-Meligui, Yomna M Int J Immunopathol Pharmacol Inflammatory Mediators in COVID-19 and Other Diseases - Original Research Article The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic resulted in more than five hundred million infected cases worldwide. The current study aimed to screen the correlation of different laboratory findings with disease severity and clinical outcomes of coronavirus disease (COVID-19) among Egyptian patients to obtain prognostic indicators of disease severity and outcome. A total of 112 laboratory-confirmed COVID-19 patients were examined. According to the severity of the disease, these patients were divided into three main groups: mild, moderate and severe cases. In addition, clinical characteristics and laboratory findings, including Hb, platelet count, white blood cell count, lymphocyte percentage, neutrophil percentage, neutrophil lymphocyte ratio (NLR), D-dimer, highly sensitive C-reactive protein (HS-CRP), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and creatinine, were measured. The presence of hypertension and/or diabetes was found to be a significant risk factor for disease severity and poor outcome. Increased respiratory rate, levels of SpO(2), HS-CRP, D-dimer, NLR, ALT, LDH, lymphopenia and neutrophilia, as well as changes in chest computed tomography (CT), were associated with increased disease severity and fatal consequences. Highly sensitive C-reactive protein, D-dimer, NLR and LDH constituted excellent predictors for both disease severity and death. Laboratory biomarkers, such as HS-CRP, D-dimer, NLR and LDH, are excellent predictors for both disease severity and death. They can predict mortality in patients at the time of admission secondary to SARS-CoV-2 infection and can help physicians identify high-risk patients before clinical deterioration. SAGE Publications 2022-05-27 /pmc/articles/PMC9150244/ /pubmed/35622504 http://dx.doi.org/10.1177/03946320221096207 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Inflammatory Mediators in COVID-19 and Other Diseases - Original Research Article
Fathalla, Lamiaa A
Kamal, Lamyaa M
Salaheldin, Omina
Khalil, Mahmoud A
Kamel, Mahmoud M
Fahim, Hagar H
Abdel-Moneim, Youssef AS
Abdulhakim, Jawaher A
Abdel-Moneim, Ahmed S
El-Meligui, Yomna M
Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
title Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
title_full Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
title_fullStr Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
title_full_unstemmed Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
title_short Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
title_sort laboratory biomarker predictors for disease progression and outcome among egyptian covid-19 patients
topic Inflammatory Mediators in COVID-19 and Other Diseases - Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150244/
https://www.ncbi.nlm.nih.gov/pubmed/35622504
http://dx.doi.org/10.1177/03946320221096207
work_keys_str_mv AT fathallalamiaaa laboratorybiomarkerpredictorsfordiseaseprogressionandoutcomeamongegyptiancovid19patients
AT kamallamyaam laboratorybiomarkerpredictorsfordiseaseprogressionandoutcomeamongegyptiancovid19patients
AT salaheldinomina laboratorybiomarkerpredictorsfordiseaseprogressionandoutcomeamongegyptiancovid19patients
AT khalilmahmouda laboratorybiomarkerpredictorsfordiseaseprogressionandoutcomeamongegyptiancovid19patients
AT kamelmahmoudm laboratorybiomarkerpredictorsfordiseaseprogressionandoutcomeamongegyptiancovid19patients
AT fahimhagarh laboratorybiomarkerpredictorsfordiseaseprogressionandoutcomeamongegyptiancovid19patients
AT abdelmoneimyoussefas laboratorybiomarkerpredictorsfordiseaseprogressionandoutcomeamongegyptiancovid19patients
AT abdulhakimjawahera laboratorybiomarkerpredictorsfordiseaseprogressionandoutcomeamongegyptiancovid19patients
AT abdelmoneimahmeds laboratorybiomarkerpredictorsfordiseaseprogressionandoutcomeamongegyptiancovid19patients
AT elmeliguiyomnam laboratorybiomarkerpredictorsfordiseaseprogressionandoutcomeamongegyptiancovid19patients